Network meta-analysis on patent foramen ovale: is a stroke or atrial fibrillation worse?

[1] Mojadidi MK(2017)Transcatheter patent foramen ovale closure after cryptogenic stroke: an updated meta-analysis of randomized trials JACC Cardiovasc Interv 10 2228-2230

[2] Elgendy AY(2018)Cryptogenic stroke and patent foramen ovale J Am Coll Cardiol 71 1035-1043

[3] Elgendy IY(2017)Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. CLOSE Investigators N Engl J Med 377 1011-1021

[4] Mahmoud AN(2017)Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. Gore REDUCE Clinical Study Investigators N Engl J Med 377 1033-1042

[5] Elbadawi A(2015)Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis Eur Heart J 36 120-128

[6] Eshtehardi P(2009)New onset atrial fibrillation after patent foramen ovale closure Catheter Cardiovasc Interv 74 889-895

[7] Patel NK(2019)New-onset atrial fibrillation following percutaneous patent foramen ovale closure: a systematic review and meta-analysis of randomised trials EuroIntervention 14 1788-1790

[8] Wayangankar S(2018)Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder) Am J Cardiol 101 1353-1358

[9] Tobis JM(2018)Closure, anticoagulation, or antiplatelet therapy for cryptogenic stroke with patent foramen ovale: systematic review of randomized trials, sequential meta-analysis, and new insights from the CLOSE Study J Am Heart Assoc 7 e008356-182

[10] Meier B(2019)Amplatzer patent foramen ovale occluder: safety and efficacy Expert Rev Med Devices 16 173-3369

[1] Mojadidi MK(2017)Transcatheter patent foramen ovale closure after cryptogenic stroke: an updated meta-analysis of randomized trials JACC Cardiovasc Interv 10 2228-2230

[2] Elgendy AY(2018)Cryptogenic stroke and patent foramen ovale J Am Coll Cardiol 71 1035-1043

[3] Elgendy IY(2017)Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. CLOSE Investigators N Engl J Med 377 1011-1021

[4] Mahmoud AN(2017)Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. Gore REDUCE Clinical Study Investigators N Engl J Med 377 1033-1042

[5] Elbadawi A(2015)Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis Eur Heart J 36 120-128

[6] Eshtehardi P(2009)New onset atrial fibrillation after patent foramen ovale closure Catheter Cardiovasc Interv 74 889-895

[7] Patel NK(2019)New-onset atrial fibrillation following percutaneous patent foramen ovale closure: a systematic review and meta-analysis of randomised trials EuroIntervention 14 1788-1790

[8] Wayangankar S(2018)Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder) Am J Cardiol 101 1353-1358

[9] Tobis JM(2018)Closure, anticoagulation, or antiplatelet therapy for cryptogenic stroke with patent foramen ovale: systematic review of randomized trials, sequential meta-analysis, and new insights from the CLOSE Study J Am Heart Assoc 7 e008356-182

[10] Meier B(2019)Amplatzer patent foramen ovale occluder: safety and efficacy Expert Rev Med Devices 16 173-3369